Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000554212 | SCV000655470 | likely benign | PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002316581 | SCV000850161 | likely benign | Inborn genetic diseases | 2016-08-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001637085 | SCV001848043 | benign | not provided | 2019-08-30 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003980023 | SCV004795515 | likely benign | PURA-related disorder | 2019-03-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |